An evaluation protocol for subtype-specific breast cancer event prediction

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Sontrop, Herman M J ^a   Verhaegh, Wim F J ^a   Reinders, Marcel J T ^b,d   Moerland, Perry D ^c,d  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS BIOINFORMATICS CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; EXPERIMENTAL MODEL; METHODOLOGY; MICROARRAY ANALYSIS; PREDICTION; SAMPLE SIZE; AREA UNDER THE CURVE; BREAST TUMOR; CLASSIFICATION; EVALUATION; FEMALE; HUMAN; PROGNOSIS;

AREA UNDER CURVE; BREAST NEOPLASMS; FEMALE; HUMANS; PROGNOSIS;

EID: 79960107964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021681     Document Type: Article

References (42)

1. van't Veer L, Dai H, van de Vijver M, He Y, Hart A, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530.
2. Weigelt B, Baehner FL, Reis-Filho JS, (2010) The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. Journal of Pathology 220: 263-280.
3. Perou C, Sørlie T, Eisen M, van de Rijn M, Jeffrey S, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
4. Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, et al. (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clinical Cancer Research 14: 5158.
5. Kapp A, Jeffrey S, Langerod A, Borresen-Dale AL, Han W, et al. (2006) Discovery and validation of breast cancer subtypes. BMC Genomics 7: 231.
6. Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF, (2006) Molecular classification of breast cancer: Limitations and potential. Oncologist 11: 868-877.
7. Weigelt B, Mackay A, A'hern R, Natrajan R, Tan D, et al. (2010) Breast cancer molecular profiling with single sample predictors: a retrospective analysis. The Lancet Oncology 11: 339-349.
8. Parker J, Mullins M, Cheang M, Leung S, Voduc D, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. Journal of Clinical Oncology 27: 1160.
9. Haibe-Kains B, Desmedt C, Rothé F, Piccart M, Sotiriou C, et al. (2010) A fuzzy gene expressionbased computational approach improves breast cancer prognostication. Genome Biology 11: R18.
10. Wang Y, Klijn J, Zhang Y, Sieuwerts A, Look M, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet 365: 671-679.
11. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. The Lancet 365: 488-492.
12. van Vliet M, Reyal F, Horlings H, van de Vijver M, Reinders M, et al. (2008) Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability. BMC genomics 9: 375.
13. Kim S, (2009) Effects of sample size on robustness and prediction accuracy of a prognostic gene signature. BMC Bioinformatics 10: 147.
14. Blagus R, Lusa L, (2010) Class prediction for high-dimensional class-imbalanced data. BMC Bioinformatics 11: 523.
15. He H, Garcia E, (2009) Learning from imbalanced data. IEEE Transactions on Knowledge and Data Engineering 21: 1263-1284.
16. Rota G, (1964) The number of partitions of a set. American Mathematical Monthly 71: 498-504.
17. Wessels L, Reinders M, Hart A, et al. (2005) A protocol for building and evaluating predictors of disease state based on microarray data. Bioinformatics 21: 3755-3762.
18. Sontrop H, Moerland P, Van Den Ham R, Reinders M, Verhaegh W, (2009) A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability. BMC Bioinformatics 10: 389.
19. Parker B, Günter S, Bedo J, (2007) Stratification bias in low signal microarray studies. BMC Bioinformatics 8: 326.
20. Baldi P, Brunak S, Chauvin Y, Andersen C, Nielsen H, (2000) Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 16: 412.
21. Perou C, Parker J, Prat A, Ellis M, Bernard P, (2010) Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncology 11: 718-719.
22. Edgar R, Domrachev M, Lash A, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research 30: 207.
23. Parkinson H, Sarkans U, Shojatalab M, Abeygunawardena N, Contrino S, et al. (2005) ArrayExpressa public repository for microarray gene expression data at the EBI. Nucleic acids research 33: D553.
24. Yu J, Sieuwerts A, Zhang Y, Martens J, Smid M, et al. (2007) Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC cancer 7: 182.
25. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the transbig multicenter independent validation series. Clinical cancer research 13: 3207.
26. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer research 68: 5405.
27. Minn A, Gupta G, Siegel P, Bos P, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
28. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt A, et al. (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. Journal of clinical oncology 25: 1239.
29. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. Journal of the National Cancer Institute 98: 262.
30. Miller L, Smeds J, George J, Vega V, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proceedings of the National Academy of Sciences of the United States of America 102: 13550.
31. Pawitan Y, Bjöhle J, Amler L, Borg A, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Research 7: R953-R964.
32. Chin K, DeVries S, Fridlyand J, Spellman P, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
33. Kauffmann A, Gentleman R, Huber W, (2009) arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415.
34. Yasrebi H, Sperisen P, Praz V, Bucher P, (2009) Can survival prediction be improved by merging gene expression data sets. PloS ONE 4: e7431.
35. McClintick J, Edenberg H, (2006) Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics 7: 49.
36. Smyth G, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3: 3.
37. Smyth G, (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor pp. 397-420.
38. Ihaka R, Gentleman R, (1996) R: A language for data analysis and graphics. Journal of computational and graphical statistics 5: 299-314.
39. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome biology 5: R80.
40. Breiman L, (2001) Random forests. Machine Learning 45: 5-32.
41. van't Veer L, Bernards R, (2008) Enabling personalized cancer medicine through analysis of geneexpression patterns. Nature 452: 564.
42. Haibe-Kains B, (2009) Identification and assessment of gene signatures in human breast cancer. Ph.D. thesis, University Libre de Bruxelles, Bioinformatics Department.